KLK3 and posterior cortical atrophy: 5-ARIs produce a hormone-mediated reduction of PSA levels, estimated at around 50% of initial value [17]; they have been studied for PCa chemoprevention, but they have shown no impact on PCa mortality and are not approved for this indication [18, 19].